MAREL Marel hf.

Marel: Transaction in own financial instruments

Marel: Transaction in own financial instruments

Viðskipti með eigin fjármálagerninga/

Transaction in own financial instruments



Nafn/Name:

Marel hf.

Dagsetning viðskipta/Date of transaction:

10.2.2021

Kaup eða sala/Buy or Sell:

Sala

Tegund fjármálagernings/Type of instrument:

Hlutabréf/Equities

Fjöldi hluta/Number of shares:

162.548

Gengi/Verð pr. Hlut/Price:

EUR 2,284

Fjöldi hluta eftir viðskipti/Primary insider's holdings after the transaction:

18.604.904

Dagsetning lokauppgjörs/Date of settlement:

Ástæður viðskipta/Reason for transaction:

Viðskiptin eru til að mæta skilyrðum um framkvæmd kaupréttarsamninga, vegna kauprétta sem veittir voru á árunum 2014, 2015, 2016 og 2017, í samræmi við starfskjarastefnu félagsins sem samþykkt var á aðalfundum félagsins á hverjum tíma.

Transaction to fulfill obligations of stock option agreements. The stock options were granted in the years 2014, 2015, 2016 and 2017 in accordance with the Company’s remuneration policy as approved by the Company’s respective AGMs.



EN
10/02/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Marel hf.

Martijn Den Drijver
  • Martijn Den Drijver

MAREL HF : A solid quarter, 2024 guidance to be met, slight delay in J...

>Beats on order intake and EBIT (margin), sales a miss, ND/EBITDA down - MAREL beat css on order intake which is encouraging, also because order intake is up both QoQ and YoY (+3%). Sales of €387m missed css by 4%, primarily because of 1/ weak ad-hoc orders as order intake has been weak for a few quarters now and 2/weak sales in Poultry and Fish. Adjusted EBIT came in at €36.2m or a margin of 9.4% versus css of €33.4m or a margin of 8.3%. That is a beat of 8% on adj....

ResearchPool Subscriptions

Get the most out of your insights

Get in touch